MMA
MDT icon

Miracle Mile Advisors’s Medtronic MDT Stock Holding History

Miracle Mile Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
14,026
+870
+7% +$70.2K 0.01% 424
2026
Q1 		$1.14M Sell
13,156
-16,173
-55% -$1.55M 0.02% 398
2025
Q4 		$2.82M Buy
29,329
+633
+2% +$61.5K 0.04% 259
2025
Q3 		$2.73M Buy
28,696
+565
+2% +$51.9K 0.04% 260
2025
Q2 		$2.45M Buy
28,131
+388
+1% +$32.9K 0.04% 233
2025
Q1 		$2.49M Buy
27,743
+812
+3% +$72.7K 0.05% 196
2024
Q4 		$2.15M Sell
26,931
-235
-0.9% -$20.3K 0.04% 221
2024
Q3 		$2.45M Sell
27,166
-1,113
-4% -$93.6K 0.06% 167
2024
Q2 		$2.23M Sell
28,279
-335
-1% -$27.5K 0.05% 178
2024
Q1 		$2.49M Sell
28,614
-332
-1% -$28.3K 0.06% 165
2023
Q4 		$2.38M Sell
28,946
-59,735
-67% -$4.55M 0.07% 158
2023
Q3 		$6.95M Buy
88,681
+542
+0.6% +$45.4K 0.21% 87
2023
Q2 		$7.77M Buy
88,139
+201
+0.2% +$17.3K 0.24% 84
2023
Q1 		$7.09M Buy
87,938
+104
+0.1% +$8.48K 0.23% 86
2022
Q4 		$6.83M Sell
87,834
-716
-0.8% -$58K 0.23% 86
2022
Q3 		$7.15M Sell
88,550
-8,766
-9% -$788K 0.33% 59
2022
Q2 		$8.73M Buy
97,316
+51,136
+111% +$5.18M 0.41% 54
2022
Q1 		$5.12M Sell
46,180
-3,175
-6% -$335K 0.22% 79
2021
Q4 		$5.11M Buy
49,355
+1,977
+4% +$229K 0.2% 97
2021
Q3 		$5.94M Buy
47,378
+6,342
+15% +$821K 0.29% 77
2021
Q2 		$5.09M Sell
41,036
-1,758
-4% -$221K 0.27% 74
2021
Q1 		$5.05M Sell
42,794
-1,480
-3% -$173K 0.29% 70
2020
Q4 		$5.19M Buy
44,274
+5,816
+15% +$640K 0.32% 70
2020
Q3 		$4M Buy
38,458
+2,829
+8% +$284K 0.28% 77
2020
Q2 		$3.27M Sell
35,629
-161
-0.4% -$15.4K 0.27% 82
2020
Q1 		$3.23M Sell
35,790
-2,400
-6% -$255K 0.35% 54
2019
Q4 		$4.33M Buy
38,190
+1,854
+5% +$203K 0.3% 70
2019
Q3 		$3.95M Buy
36,336
+25,862
+247% +$2.7M 0.28% 78
2019
Q2 		$1.02M Buy
+10,474
New +$956K 0.08% 152

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Miracle Mile Advisors's MDT Position: Q2 2026 in Review

Miracle Mile Advisors increased its Medtronic (MDT) stake by 6.6% in Q2 2026, buying an estimated $70.2K and bringing the position to 14,026 shares worth $1.1M. The position accounts for 0.01% of the portfolio, ranked #424.

Miracle Mile Advisors first reported a position in MDT in Q2 2019 and has held it in 29 quarters since. The position peaked at $8.73M in Q2 2022. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Miracle Mile Advisors held 14,026 shares of Medtronic worth $1.1M as of Q2 2026.
  • Miracle Mile Advisors bought 870 Medtronic shares in Q2 2026, an estimated $70.2K.
  • Medtronic made up 0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #424 holding.
  • Miracle Mile Advisors first reported a position in Medtronic in Q2 2019 and has held it in 29 quarters since.
  • Miracle Mile Advisors's Medtronic position peaked at $8.73M in Q2 2022.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.